BIONIK LABORATORIES CORP. (OTCMKTS:BNKL) Files An 8-K Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain OfficersItem 5.02
BIONIK LABORATORIES CORP. (OTCMKTS:BNKL) Files An 8-K Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers
Departure of Directors or Principal Officers; Election of Directors; Appointment of Principal Officers
Jules Fried, the Vice President, US Operations of Bionik Laboratories Corp. (the “Company”), will be leaving the Company’s employment in April 2017. In mid-2015, Mr. Fried joined Interactive Motion Technologies, Inc. (“IMT”) to assist with its management, culminating in his role as Chief Executive Officer of IMT. Upon the Company’s acquisition of IMT in April 2016, Mr. Fried remained with the Company and, among other things, assisted with the integration of the two companies, which is now complete. The Company expects that Mr. Fried’s roles with the Company will be absorbed by existing management.
About BIONIK LABORATORIES CORP. (OTCMKTS:BNKL)
Bionik Laboratories Corp. (Bionik), formerly Drywave Technologies, Inc., is a medical device and robotics company. The Company is focused on providing rehabilitation solutions and developing transformational technologies and solutions to individuals with neurological disorders, specializing in the designing, developing and commercializing of physical rehabilitation technologies, prosthetics and assisted robotic products. It has over three products on the market and approximately three products in various stages of development. The InMotion Systems include the InMotion ARM, InMotion HAND, InMotion Wrist and InMotion ANKLE are designed to provide patent-adaptive therapy in a manner that has been clinically verified to manage neuro-recovery. The Company is also engaged in developing a lower-body exoskeleton, ARKE, which designs to allow paraplegics, as well as other wheelchair users the ability to rehabilitate through walking. BIONIK LABORATORIES CORP. (OTCMKTS:BNKL) Recent Trading Information
BIONIK LABORATORIES CORP. (OTCMKTS:BNKL) closed its last trading session 00.000 at 0.510 with 2,000 shares trading hands.
Bionik Laboratories Corp. (Bionik), formerly Drywave Technologies, Inc., is a medical device and robotics company. The Company is focused on providing rehabilitation solutions and developing transformational technologies and solutions to individuals with neurological disorders, specializing in the designing, developing and commercializing of physical rehabilitation technologies, prosthetics and assisted robotic products. It has over three products on the market and approximately three products in various stages of development. The InMotion Systems include the InMotion ARM, InMotion HAND, InMotion Wrist and InMotion ANKLE are designed to provide patent-adaptive therapy in a manner that has been clinically verified to manage neuro-recovery. The Company is also engaged in developing a lower-body exoskeleton, ARKE, which designs to allow paraplegics, as well as other wheelchair users the ability to rehabilitate through walking. BIONIK LABORATORIES CORP. (OTCMKTS:BNKL) Recent Trading Information
BIONIK LABORATORIES CORP. (OTCMKTS:BNKL) closed its last trading session 00.000 at 0.510 with 2,000 shares trading hands.
